Euretos [‘findable’], was founded in 2012 and enables researchers at world leading pharma, biotech and academic institutions to accelerate life sciences research. We support private as well as publicly funded research organisations.
Enable Precision Medicine & Breeding
The individual geno- and phenotype of any organism (human, animal or plant) is as personal as, for instance, a tattoo. Our platform is uniquely able to identify the specific genetic, multi-omic and phenotypic interactions that enables true precision medicine & breeding research.
EURETOS AI PLATFORM
References & Partners
We work with some of most advanced life sciences research organisations in the world that including pharma companies, biotechs, academic institutes, research hospitals and publishers. Our customers range from very large to small and mid-size organisations. A sample of our references is available below. We also regularly participate as a technology provider in government funded fundamental research projects.
Prof David Webb (The Scripps Research Institute)
“The Euretos AI Platform is nothing less than an in silico way to save all drug and biotech researchers an infinite amount of blood, sweat and tears by providing
them with a powerful knowledge discovery platform.
The Euretos AI Platform allows the researcher to rapidly assess whether a given target, research area, etc., is related, even distantly, to another such entity thus allowing one to uncover hidden connections, leading to new knowledge.In the drug discovery arena, this thing is a gold mine.
Louis Braillelaan 80,
2719 EK Zoetermeer
+31 (0)79 - 7999515